Article
LANCET  (2016)

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries=> an analysis of the PURE study data

Khatib R., McKee M.; Shannon H., Chow C.; Rangarajan S., Teo K.; Wei L., Mony P.; Mohan V., Gupta R.; Kumar R., Vijayakumar K.; Lear S.A., Díaz R; Avezum A., López-Jaramillo P.; Lanas F., Yusoff K.; Ismail N., Kazmi K.; Rahman O., Rosengren A.; Monsef N., Kelishadi R.; Kruger A., Puoane T.; Szuba A., Chifamba J.; Temizhan A., Dagenais G.; Gafni A., Yusuf S.